Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn’s disease

by Ariela K. Holmer, Robert Battat, Parambir S. Dulai, Niels Vande Casteele, Nghia Nguyen, Anjali Jain, Ara Miralles, Jennifer Neill, Helen Le, Siddharth Singh, Jesus Rivera-Nieves, William J. Sandborn, Brigid S. Boland
Published 2020-11-01